Scroll To Top
Health

FDA approves more generic anti-HIV drugs

FDA approves more generic anti-HIV drugs

Support The Advocate
LGBTQ+ stories are more important than ever. Join us in fighting for our future. Support our journalism.

The Food and Drug Administration on Wednesday granted tentative approval to 150-milligram and 300-milligram generic versions of the brand-name anti-HIV drug Epivir (3TC). The generic medication, made by India-based Aurobindo Pharma, will be available for purchase and distribution in developing countries through the President's Emergency Plan for AIDS Relief. The generic pills will not be available in the United States or other Western countries. The drug approved Wednesday is the second generic version of Epivir approved by the FDA since May for PEPFAR use.

Stonewall Brick AwardsOut / Advocate Magazine - Jonathan Groff & Wayne Brady

From our Sponsors

Most Popular

Latest Stories

Outtraveler Staff